DIMETAPP CHEWABLES FOR KIDS 2.5 MG
PHENYLEPHRINE HYDROCHLORIDE : 2.5 MG BROMPHENIRAMINE MALEATE : 1.0 MG · DIN 02277239 · PFIZER CONSUMER HEALTHCARE A DIVISION OF PFIZER CANADA ULC
Health Canada status: CANCELLED POST MARKET
What is DIMETAPP CHEWABLES FOR KIDS?
DIMETAPP CHEWABLES FOR KIDS 2.5 MG contains PHENYLEPHRINE HYDROCHLORIDE : 2.5 MG BROMPHENIRAMINE MALEATE : 1.0 MG. It is listed in the Health Canada Drug Product Database under DIN 02277239, held by PFIZER CONSUMER HEALTHCARE A DIVISION OF PFIZER CANADA ULC, supplied as TABLET (CHEWABLE) for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 04-Aug-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02277239 |
|---|---|
| Brand name | DIMETAPP CHEWABLES FOR KIDS |
| Generic / active ingredient | PHENYLEPHRINE HYDROCHLORIDE : 2.5 MG BROMPHENIRAMINE MALEATE : 1.0 MG |
| Manufacturer | PFIZER CONSUMER HEALTHCARE A DIVISION OF PFIZER CANADA ULC |
| Strength | 2.5 MG |
| Dosage form | TABLET (CHEWABLE) |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R01BA53 PHENYLEPHRINE, COMBINATIONS |
| AHFS class | 12:12.00 ; 04:04.20 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 04-Aug-2017 |
| Original market date | 2006-08-01 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code R01BA53 PHENYLEPHRINE, COMBINATIONS. 0 of 24 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACTIFED PE | 4 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | CANCELLED PRE MARKET | DIN 02273845 |
| CHILDREN'S BENADRYL-D SYRUP | 12.5 MG / 5 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | CANCELLED POST MARKET | DIN 02280612 |
| COLD & STUFFY NOSE | 2.5 MG / 5 ML | LIQUID | ACCUDIAL PHARMACEUTICAL INC | CANCELLED POST MARKET | DIN 02328402 |
| COLD LIQUID | 2 MG / 5 ML | SOLUTION | ARA-AVANTI RX ANALYTICS INC | CANCELLED PRE MARKET | DIN 02468212 |
| COLD LIQUID | 2 MG / 5 ML | SOLUTION | TANTA PHARMACEUTICALS INC | DORMANT | DIN 02267411 |
| COLD LIQUID GRAPE FLAVOUR | 2 MG / 5 ML | SOLUTION | CELLCHEM PHARMACEUTICALS INC. | DORMANT | DIN 02315475 |
| COLD SYRUP | 5 MG / 5 ML | SYRUP | JAMP PHARMA CORPORATION | DORMANT | DIN 02266180 |
| DIMETAPP | 5 MG / 5 ML | SYRUP | FOUNDATION CONSUMER BRANDS, LLC | CANCELLED POST MARKET | DIN 02243980 |
| DIMETAPP EXTRA STRENGTH | 10 MG / 5 ML | SYRUP | FOUNDATION CONSUMER BRANDS, LLC | CANCELLED POST MARKET | DIN 02245075 |
| DIMETAPP ORAL INFANT COLD DROPS | 0.5 MG | LIQUID | WYETH CONSUMER HEALTHCARE INC. | CANCELLED POST MARKET | DIN 02243945 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.